For Publishers
DiscoveryMetadataPeer reviewHostingPublishing
For Researchers
JoinPublishReviewCollect
Register
Blog
About
Search
Advanced search
My ScienceOpen
Search
For Publishers
For Researchers
Blog
About
14
views
15
references
 Top references
cited by
40
    
0 reviews
 Review
0
comments
 Comment
0
recommends
+1 Recommend
0 collections
    0
    shares
      3,792
      similar
       All similar
      • Record: found
      • Abstract: not found
      • Article: not found

      Efficacy of Guselkumab Compared With Adalimumab and Placebo for Psoriasis in Specific Body Regions : A Secondary Analysis of 2 Randomized Clinical Trials

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Psoriasis of the scalp, palms and/or soles, and nails is challenging to treat.

          Related collections

          Most cited references15

          • Record: found
          • Abstract: found
          • Article: not found

          Nail Psoriasis Severity Index: a useful tool for evaluation of nail psoriasis.

          Phoebe Rich, R K Scher (2003)
          The Nail Psoriasis Severity Index (NAPSI) is a numeric, reproducible, objective, simple tool for evaluation of nail psoriasis. This scale is used to evaluate the severity of nail bed psoriasis and nail matrix psoriasis by area of involvement in the nail unit. The NAPSI will be useful during clinical trials for evaluating response to treatment of psoriatic nails. The scale is reproducible, and because there are few data points, statistical analysis is simplified.
          Article 0 comments Cited 123 times – based on 0 reviews     Review now
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found
            Is Open Access

            Secukinumab shows significant efficacy in palmoplantar psoriasis: Results from GESTURE, a randomized controlled trial.

            Anne Parneix, Alice B Gottlieb, John Sullivan … (2017)
            Plaque psoriasis affecting palms and soles is disabling and often resistant to treatment.
            Article 0 comments Cited 50 times – based on 0 reviews     Review now
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Baseline nail disease in patients with moderate to severe psoriasis and response to treatment with infliximab during 1 year.

              Chun Liang Hsu, R K Scher, Stephen Xu … (2008)
              Although nail psoriasis occurs frequently in patients with psoriatic skin lesions, effective treatments are limited. Occurrence of nail psoriasis by type and incidence of nail clearance using the Nail Psoriasis Severity Index were evaluated. This was a 50-week, phase III study in which 378 patients with moderate to severe psoriasis were randomized 4:1 to infliximab (5 mg/kg) or placebo at weeks 0, 2, 6, and every 8 weeks through week 46, with placebo crossover to infliximab at week 24. Of the 373 evaluated patients, 305 (81.8%) had baseline nail psoriasis. The right thumbnail was most often the worst involved nail, and pitting and onycholysis were the most common lesions. Among patients with baseline nail psoriasis, 6.9%, 26.2%, and 44.7% in the infliximab group had nail disease clearance at weeks 10, 24, and 50, respectively, versus 5.1% in the placebo group at week 24 (P < .001). Mean percent improvements in Nail Psoriasis Severity Index score at weeks 10 and 24 were 26.8% and 57.2%, respectively, in the infliximab group versus -7.7% and -4.1%, respectively, in the placebo group (both P < .001). At week 24, mean percent improvements in nail matrix and nail bed features were 52.9% and 69.2%, respectively (vs -1.9% and 18.4% for placebo; P < .001). The study did not evaluate nail response beyond 1 year. Patients with psoriasis receiving infliximab experienced marked and sustained nail improvement.
              Article 0 comments Cited 45 times – based on 0 reviews     Review now
                Bookmark
                All references

                Author and article information

                Journal
                Title: JAMA Dermatology
                Abbreviated Title: JAMA Dermatol
                Publisher: American Medical Association (AMA)
                ISSN (Print): 2168-6068
                Publication date Created: June 01 2018
                Publication date (Print): June 01 2018
                Volume: 154
                Issue: 6
                Page: 676
                Affiliations
                [1 ]Department of Medicine, The University of Melbourne, St Vincent’s Hospital, Melbourne, Victoria, Australia
                [2 ]Skin & Cancer Foundation Inc, Carlton, Victoria, Australia
                [3 ]Department of Dermatology, Medical College of Wisconsin, Milwaukee
                [4 ]Dermatology Centre, Salford Royal Hospital, University of Manchester, Manchester Academic Health Science Centre, Manchester, England
                [5 ]Janssen Research & Development, LLC, Spring House, Pennsylvania
                [6 ]Oregon Medical Research Center, Portland
                Article
                DOI: 10.1001/jamadermatol.2018.0793
                PMC ID: 6145649
                PubMed ID: 29799960
                SO-VID: 711efb81-ff8e-4b7c-bdc6-9d5059a0beed
                Copyright © © 2018
                History

                Data availability:

                Comments

                Comment on this article

                scite_

                Similar content3,792

                See all similar

                Cited by40

                See all cited by

                Most referenced authors152

                See all reference authors